galantamine has been researched along with mecamylamine in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 11 (64.71) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Vogel, RW; Wenk, GL; Woodruff-Pak, DS | 1 |
Badia, A; Camps, P; Clos, MV; Roman, S | 1 |
Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S | 1 |
Ivanov, VB; Schilström, B; Svensson, TH; Wiker, C | 1 |
Akaike, A; Fujii, T; Katsuki, H; Kume, T; Niidome, T; Okabe, S; Sugimoto, H; Sugimoto, M; Takada-Takatori, Y | 1 |
Arias, E; García, AG; López, MG; Lorrio, S; Roda, JM; Sobrado, M | 1 |
Ago, Y; Baba, A; Hashimoto, H; Kawasaki, T; Koda, K; Matsuda, T | 1 |
Kuryatov, A; Lindstrom, J; Onksen, J | 1 |
Kishimoto, K; Kitamura, Y; Minamino, H; Shibaike, T; Shimohama, S; Takata, K; Takeuchi, H; Taniguchi, T; Tsushima, J; Yanagida, T; Yasui, H | 1 |
Ago, Y; Kawasaki, T; Kobayashi, H; Koda, K; Matsuda, T; Takuma, K; Yano, K | 1 |
Asanuma, M; Azuma, K; Nanba, T; Ogo, H; Shimakoshi, R; Tamura, A; Tanaka, K; Yagi, T | 1 |
Egea, J; García, AG; López, MG; Romero, A | 1 |
Federley, M; Fjällström, AK; Persson, P; Stenqvist, P; Wadenberg, ML | 1 |
Lai, M; Liu, H; Liu, Y; Ma, B; Sun, A; Zhang, F; Zhou, W; Zhou, X; Zhu, H | 1 |
Alvarez-Jimenez, R; Cohen, AF; de Kam, M; Groeneveld, GJ; Hart, EP; Prins, S; van Gerven, JMA | 1 |
Groeneveld, GJ; Hart, EP; Linkenkaer-Hansen, K; Mansvelder, HD; Poil, SS; Prins, S; Simpraga, S | 1 |
1 review(s) available for galantamine and mecamylamine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for galantamine and mecamylamine
Article | Year |
---|---|
Reversal of mecamylamine-induced effects in healthy subjects by nicotine receptor agonists: Cognitive and (electro) physiological responses.
Topics: Adolescent; Adult; Cognition; Cross-Over Studies; Double-Blind Method; Drug Interactions; Electroencephalography; Galantamine; Healthy Volunteers; Humans; Male; Mecamylamine; Middle Aged; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Reaction Time; Young Adult | 2018 |
An EEG nicotinic acetylcholine index to assess the efficacy of pro-cognitive compounds.
Topics: Adolescent; Adult; Brain Waves; Cholinesterase Inhibitors; Cognition; Drug Evaluation; Galantamine; Humans; Machine Learning; Male; Mecamylamine; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Nootropic Agents | 2018 |
14 other study(ies) available for galantamine and mecamylamine
Article | Year |
---|---|
Mecamylamine interactions with galantamine and donepezil: effects on learning, acetylcholinesterase, and nicotinic acetylcholine receptors.
Topics: Acetylcholinesterase; Animals; Cholinesterase Inhibitors; Donepezil; Drug Interactions; Female; Galantamine; Indans; Learning; Mecamylamine; Piperidines; Rabbits; Receptors, Nicotinic | 2003 |
Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
Topics: Acetylcholine; Aminoquinolines; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Galantamine; Heterocyclic Compounds, 4 or More Rings; Male; Mecamylamine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptosomes | 2004 |
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes | 2005 |
Galantamine enhances dopaminergic neurotransmission in vivo via allosteric potentiation of nicotinic acetylcholine receptors.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Analysis of Variance; Animals; Cholinesterase Inhibitors; Donepezil; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Galantamine; Indans; Male; Mecamylamine; Microdialysis; Neurons; Nicotinic Antagonists; Piperidines; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptic Transmission; Ventral Tegmental Area | 2007 |
Neuroprotective effects of galanthamine and tacrine against glutamate neurotoxicity.
Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Cysteine; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Fetus; Galantamine; Glutamic Acid; Ionomycin; Ionophores; Mecamylamine; Neuroprotective Agents; Nicotinic Antagonists; Nitric Oxide Donors; Rats; Rats, Wistar; S-Nitrosothiols; Tacrine | 2006 |
Galantamine postischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils.
Topics: Animals; Apoptosis; Brain Ischemia; Carotid Artery, Common; Caspase 3; Galantamine; Gerbillinae; Hippocampus; Male; Mecamylamine; Memory Disorders; Pyramidal Cells; Reperfusion Injury; Superoxide Dismutase | 2007 |
Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.
Topics: Aconitine; Acoustic Stimulation; alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Cholinesterase Inhibitors; Dizocilpine Maleate; Donepezil; Dose-Response Relationship, Drug; Galantamine; Indans; Male; Mecamylamine; Mice; Neural Inhibition; Nicotinic Antagonists; Piperidines; Receptors, Nicotinic; Reflex, Startle; Risperidone; Social Isolation | 2008 |
Roles of accessory subunits in alpha4beta2(*) nicotinic receptors.
Topics: Acetylcholine; Allosteric Regulation; Antibodies, Monoclonal; Binding Sites; Biotinylation; Bridged Bicyclo Compounds, Heterocyclic; Cell Line; Galantamine; Humans; Inhibitory Concentration 50; Kidney; Mecamylamine; Mutation; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Radioimmunoassay; Receptors, Nicotinic; Transfection; Up-Regulation | 2008 |
Synergistic effect of galantamine on nicotine-induced neuroprotection in hemiparkinsonian rat model.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Disease Models, Animal; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Electron Spin Resonance Spectroscopy; Functional Laterality; Galantamine; Gene Expression Regulation; Male; Mecamylamine; Methamphetamine; Motor Activity; Neuroprotective Agents; Nicotine; Nicotinic Antagonists; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Nicotinic; RNA, Messenger; Rotarod Performance Test; Tyrosine 3-Monooxygenase | 2008 |
Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.
Topics: Acetylcholine; Acoustic Stimulation; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Benzazepines; Cholinesterase Inhibitors; Donepezil; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Galantamine; Indans; Inhibition, Psychological; Male; Mecamylamine; Mice; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nicotinic Antagonists; Oxotremorine; Piperidines; Pirenzepine; Prefrontal Cortex; Receptors, Muscarinic; Reflex, Startle; Serotonin | 2009 |
Effects of galantamine on L-NAME-induced behavioral impairment in Y-maze task in mice.
Topics: Animals; Behavior, Animal; Cholinesterase Inhibitors; Galantamine; Hippocampus; Male; Maze Learning; Mecamylamine; Mice; Mice, Inbred ICR; NG-Nitroarginine Methyl Ester; Nicotinic Antagonists; Nitric Oxide; Nitric Oxide Synthase; Nootropic Agents | 2009 |
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
Topics: Analysis of Variance; Cell Death; Cell Line, Tumor; Drug Synergism; Galantamine; Histocytochemistry; Humans; Mecamylamine; Melatonin; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Signal Transduction; Tryptamines | 2010 |
Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Behavior, Animal; Catalepsy; Cholinergic Antagonists; Cholinesterase Inhibitors; Disease Models, Animal; Extrapyramidal Tracts; Galantamine; Haloperidol; Male; Mecamylamine; Motor Activity; Nicotinic Antagonists; Rats; Rats, Wistar; Receptors, Muscarinic; Risperidone; Schizophrenia; Scopolamine | 2011 |
Galantamine attenuates the heroin seeking behaviors induced by cues after prolonged withdrawal in rats.
Topics: Animals; Behavior, Animal; Cholinergic Antagonists; Cholinesterase Inhibitors; Cues; Drug-Seeking Behavior; Extinction, Psychological; Galantamine; Heroin; Mecamylamine; Motor Activity; Narcotics; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Scopolamine; Self Administration; Substance Withdrawal Syndrome; Ventral Tegmental Area | 2012 |